Company Profile

KromaTiD Inc
Profile last edited on: 9/21/22      CAGE: 4U2V4      UEI: YTHLMBHDYM55

Business Identifier: Genomic structural variation analysis for CRISPR, cancer and genetic diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1880 Industrial Drive Suite A
Longmont, CO 80501
   (303) 775-1512
Location: Single
Congr. District: 04
County: Boulder

Public Profile

With ties to Colorado State University Fort Collins, KromaTiD is organized around advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents. The firm is developing a method and kit using chromatid paints to detect chromosomal inversions. Small chromosome inversions are virtually invisible using the cytogenetic methods currently in use. KromaTiD's molecular cytogenetic and GeneTracker® assays discover, detect and diagnose the widest range of disease causing mutations - including inversions and translocations - in a single test. Based on Directional Genomic Hybridization (dGH), KromaTiD's assays generate sequence, location and orientation data from single cells, making them ideal for mixed cell population studies.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Christopher Tompkins -- President & CEO

  Susan M Bailey -- Scientific Founder

  Joel S Bedford -- Scientific Founder

  Michael Cornforth -- Scientific Founder

  Edwin Goodwin -- Scientific Founder

  Terry Opgeneorth -- Chairman of the Board

  Gretchen Pratt -- Senior Director of Operations

  Bruce Robinson -- Board Member

  Erin Robinson -- Research Manager

  David Sebesta -- Chief Commercial Officer